| Journal | Cannabis and cannabinoid research |
| Study Type | Pilot Study |
| Population | Human participants |
This pilot study provides the first direct evidence that chronic cannabis use may disrupt the body’s natural endocannabinoid response to exercise, potentially affecting mood and pain regulation. Understanding how exogenous cannabinoids interact with our endogenous system is crucial for optimizing therapeutic outcomes and managing potential tolerance or withdrawal effects.
This pilot study compared 20 adults, examining anandamide (AEA) levels before and after standardized exercise in cannabis users versus controls. Cannabis users showed significantly blunted AEA response to exercise (0.33 vs 0.47 ng/mL), along with worse mood and increased pain during and after exercise. The findings suggest that chronic cannabis exposure may downregulate the endogenous cannabinoid system’s natural response to physiological stimuli. As a pilot study with a small sample size, these results require replication in larger, more diverse populations.
“This aligns with what I observe clinically—patients using cannabis regularly often report needing higher doses over time and may experience mood or pain changes during tolerance breaks. The study provides biological plausibility for why some patients struggle with exercise motivation or pain management when using cannabis chronically.”
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
FAQ
How does regular cannabis use affect the body’s natural endocannabinoid response to exercise?
Regular cannabis users showed significantly lower anandamide (AEA) concentrations at the end of exercise compared to non-users (0.33 vs. 0.47 ng/mL). This suggests that chronic cannabis use may blunt the body’s natural endocannabinoid response to physical activity, potentially indicating tolerance or dysregulation of the endocannabinoid system.
Does cannabis use impact exercise performance and recovery?
According to this study, habitual cannabis users experienced worse mood and more pain both during and after exercise compared to controls. The diminished anandamide response may contribute to reduced exercise tolerance and could potentially affect exercise adherence and recovery.
What are the clinical implications for patients using cannabis medicinally?
These findings suggest that regular cannabis use may alter the endocannabinoid system’s natural functioning, which could impact pain management and mood regulation. Clinicians should consider that patients using cannabis long-term may experience altered responses to natural endocannabinoid-mediated processes like exercise-induced analgesia.
Could these findings be relevant to cannabis withdrawal symptoms?
The blunted anandamide response observed in regular users may help explain some cannabis withdrawal symptoms, particularly mood changes and altered pain perception. When cannabis use is discontinued, the already-compromised endocannabinoid system may struggle to maintain normal physiological functions.
Should healthcare providers modify exercise recommendations for cannabis users?
While this is preliminary data from a small pilot study, it suggests cannabis users may experience exercise differently than non-users. Healthcare providers might need to consider modified approaches to exercise therapy and pain management in patients with regular cannabis use, though more research is needed to establish clinical guidelines.
